161 related articles for article (PubMed ID: 12000986)
1. Susceptibility of Brazilian staphylococcal strains to glycopeptides evaluated by different testing methods.
Ferreira Nunes AP; Martins Teixeira L; Reis Bastos CC; de Souza Fonseca L; Netto dos Santos KR
Curr Microbiol; 2002 Jun; 44(6):385-90. PubMed ID: 12000986
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis and validation of different assays for glycopeptide susceptibility among methicillin-resistant Staphylococcus aureus strains.
Bernard L; Vaudaux P; Rohner P; Huggler E; Armanet M; Pittet D; Lew DP; Schrenzel J
J Microbiol Methods; 2004 May; 57(2):231-9. PubMed ID: 15063063
[TBL] [Abstract][Full Text] [Related]
3. [Comparative in vitro activity of glycopeptides against coagulase negative staphylococci isolated in pediatric hospital units].
Bourgeois F; Bingen E; Lambert-Zechovsky N
Pathol Biol (Paris); 1992 Jan; 40(1):36-9. PubMed ID: 1533278
[TBL] [Abstract][Full Text] [Related]
4. [Investigation of glycopeptide resistance in methicillin resistant staphylococcal isolates].
Hoşgör Limoncu M; Ermertcan S; Taşli H; Kurutepe S
Mikrobiyol Bul; 2007 Oct; 41(4):511-6. PubMed ID: 18173069
[TBL] [Abstract][Full Text] [Related]
5. Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals.
Nonhoff C; Denis O; Struelens MJ
Clin Microbiol Infect; 2005 Mar; 11(3):214-20. PubMed ID: 15715719
[TBL] [Abstract][Full Text] [Related]
6. Activity of dalbavancin against staphylococci and streptococci, assessed by BSAC and NCCLS agar dilution methods.
Mushtaq S; Warner M; Johnson AP; Livermore DM
J Antimicrob Chemother; 2004 Sep; 54(3):617-20. PubMed ID: 15321983
[TBL] [Abstract][Full Text] [Related]
7. [Prospective study of Staphylococcus aureus with reduced susceptibility to glycopeptides].
Cantón R; Mir N; Martínez-Ferrer M; Sánchez del Saz B; Soler I; Baquero F
Rev Esp Quimioter; 1999 Mar; 12(1):48-53. PubMed ID: 10896469
[TBL] [Abstract][Full Text] [Related]
8. Characterisation of coagulase-negative staphylococci isolated from blood infections: incidence, susceptibility to glycopeptides, and molecular epidemiology.
Boisson K; Thouverez M; Talon D; Bertrand X
Eur J Clin Microbiol Infect Dis; 2002 Sep; 21(9):660-5. PubMed ID: 12373498
[TBL] [Abstract][Full Text] [Related]
9. [In vitro activity of glycopeptides on 114 coagulase-negative staphylococci: problems with the teicoplanin diffusion test, "alert" parameters indicating need for MIC determination].
Jean-Pierre H; Rivière M; Darbas H; Boyer G
Pathol Biol (Paris); 1993 Jun; 41(6):531-6. PubMed ID: 8247632
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of Staphylococcus aureus and coagulase-negative staphylococci with decreased sensitivity to glycopeptides as assessed by determination of MICs.
Vedel G; Leruez M; Lémann F; Hraoui E; Ratovohery D
Eur J Clin Microbiol Infect Dis; 1990 Nov; 9(11):820-2. PubMed ID: 2150815
[TBL] [Abstract][Full Text] [Related]
11. Methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to glycopeptides (GISA) in 63 French general hospitals.
Cartolano GL; Cheron M; Benabid D; Leneveu M; Boisivon A;
Clin Microbiol Infect; 2004 May; 10(5):448-51. PubMed ID: 15113324
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides.
Walsh TR; Bolmström A; Qwärnström A; Ho P; Wootton M; Howe RA; MacGowan AP; Diekema D
J Clin Microbiol; 2001 Jul; 39(7):2439-44. PubMed ID: 11427551
[TBL] [Abstract][Full Text] [Related]
13. A 1 year surveillance study of glycopeptide-intermediate Staphylococcus aureus strains in a French hospital.
Garnier F; Chainier D; Walsh T; Karlsson A; Bolmström A; Grelaud C; Mounier M; Denis F; Ploy MC
J Antimicrob Chemother; 2006 Jan; 57(1):146-9. PubMed ID: 16286482
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility of staphylococci and enterococci to glycopeptides comparison of 3 test methods.
Jansen B; Schumacher-Perdreau F; Pulverer G
Zentralbl Bakteriol; 1995 Oct; 282(4):402-8. PubMed ID: 9810663
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial susceptibility of coagulase-negative staphylococci and characterization of isolates with reduced susceptibility to glycopeptides.
Del' Alamo L; Cereda RF; Tosin I; Miranda EA; Sader HS
Diagn Microbiol Infect Dis; 1999 Jul; 34(3):185-91. PubMed ID: 10403098
[TBL] [Abstract][Full Text] [Related]
16. Low-level resistance to glycopeptides amongst staphylococcus species: surveillance in a university hospital and evaluation of a vancomycin screening agar.
Park YJ; Jun Park J; Lee SO; Oh EJ; Kee Kim B
Diagn Microbiol Infect Dis; 2001 Nov; 41(3):155-9. PubMed ID: 11750170
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD
Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility of gram positive cocci to teicoplanin. Three year survey (1984-1986) at Perugia University.
Pasticci MB; Baldelli F; Moretti A; Menichetti F; Pauluzzi S
Boll Ist Sieroter Milan; 1989; 68(1):5-6. PubMed ID: 2535245
[TBL] [Abstract][Full Text] [Related]
19. Glycopeptide and oxacillin activity against Staphylococcus aureus isolates at a tertiary care center in Lebanon.
Kanj SS; Ghaleb PA; Araj GF
J Med Liban; 2004; 52(1):8-12. PubMed ID: 15881695
[TBL] [Abstract][Full Text] [Related]
20. Selection of resistance to glycopeptide antibiotics in staphylococci.
Biavasco F; Giovanetti E; Varaldo PE
J Chemother; 1991 Jan; 3 Suppl 1():166-8. PubMed ID: 12041756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
